SCHEMBL6450337

SCHEMBL6450337

CCCCC(CNOCc1ccccc1)C(=O)OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
BIRC2 Q13490 1/20 0.45
CTSL P07711 1/20 0.45
CTSS P25774 1/20 0.45
CNR2 P34972 1/20 0.44
TSHR P16473 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MBOAT4 Q96T53 1/20 0.43
CTSK P43235 2/20 0.42
FOLH1 Q04609 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4169167 1.00 CA1 (0.49) CA1CA2BIRC2CTSLCTSS
SCHEMBL4169164 1.00 CA1 (0.49) CA1CA2BIRC2CTSLCTSS
SCHEMBL15048701 0.96 BIRC2 (0.49) CA1CA2BIRC2CNR2TSHR
SCHEMBL15048738 0.91 HSD17B10 (0.46) CTSLCTSSCNR2TSHRALDH1A1
SCHEMBL4955699 0.89 PTGES (0.48) CA2CTSLCTSSCNR2TSHR
SCHEMBL3319286 0.89 PTGES (0.48) CA2CTSLCTSSCNR2TSHR
SCHEMBL15048672 0.87 LMNA (0.44) BIRC2CNR2TSHRL3MBTL1MBOAT4
SCHEMBL134381 0.85 CTRC (0.48) BIRC2CNR2FOLH1PTGESALOX5
SCHEMBL134382 0.85 CTRC (0.48) BIRC2CNR2FOLH1PTGESALOX5
SCHEMBL8054966 0.84 CTRC (0.50) CNR2CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130177963-A1 ASYMMETRIC HYDROLASE AND GENE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-07-11 US disclosed
EP-2607480-A1 Asymmetric hydrolase and gene thereof Sumitomo Chemical Company, Limited (JP) 2013-06-26 EP disclosed
EP-1599440-A2 CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS Novartis AG (CH) 2005-11-30 EP disclosed
WO-2004076053-A2 CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS NOVARTIS AG (CH) 2004-09-10 WO disclosed